SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    George N. Ioannou, Christopher L. Bryson, Noel S. Weiss, Edward J. Boyko, Associations between lipodystrophy or antiretroviral medications and cirrhosis in patients with HIV infection or HIV/HCV coinfection, European Journal of Gastroenterology & Hepatology, 2015, 27, 5, 577

    CrossRef

  2. 2
    Lauren A. Beste, Pamela K. Green, George N. Ioannou, Boceprevir and telaprevir-based regimens for the treatment of hepatitis C virus in HIV/HCV coinfected patients, European Journal of Gastroenterology & Hepatology, 2015, 27, 2, 123

    CrossRef

  3. 3
    Ani A. Kardashian, Jennifer C. Price, Hepatitis C virus–HIV-coinfected patients and liver transplantation, Current Opinion in Organ Transplantation, 2015, 20, 3, 276

    CrossRef

  4. 4
    C Cooper, KC Rollet-Kurhajec, J Young, C Vasquez, M Tyndall, J Gill, N Pick, S Walmsley, MB Klein, HIV virological rebounds but not blips predict liver fibrosis progression in antiretroviral-treated HIV/hepatitis C virus-coinfected patients, HIV Medicine, 2015, 16, 1
  5. 5
    Maïté Lewin, Moana Gelu-Simeon, Marita Ostos, Faroudy Boufassa, Rodolphe Sobesky, Elina Teicher, Laurence Meyer, Hélène Fontaine, Dominique Salmon-Céron, Didier Samuel, Olivier Seror, Jean-Claude Trinchet, Jean-Charles Duclos-Vallée, Imaging Features and Prognosis of Hepatocellular Carcinoma in Patients with Cirrhosis Who are Coinfected with Human Immunodeficiency Virus and Hepatitis C Virus, Radiology, 2015, 141500

    CrossRef

  6. 6
    Jean-Michel Molina, Chloe Orkin, David M Iser, Francisco-Xavier Zamora, Mark Nelson, Christoph Stephan, Benedetta Massetto, Anuj Gaggar, Liyun Ni, Evguenia Svarovskaia, Diana Brainard, G Mani Subramanian, John G McHutchison, Massimo Puoti, Jürgen K Rockstroh, Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 study, The Lancet, 2015, 385, 9973, 1098

    CrossRef

  7. 7
    Jennifer R. Kramer, Marc A. Kowalkowski, Zhigang Duan, Elizabeth Y. Chiao, The Effect of HIV Viral Control on the Incidence of Hepatocellular Carcinoma in Veterans With Hepatitis C and HIV Coinfection, JAIDS Journal of Acquired Immune Deficiency Syndromes, 2015, 68, 4, 456

    CrossRef

  8. 8
    Moana Gelu-Simeon, Rodolphe Sobesky, Stéphanie Haïm-Boukobza, Marita Ostos, Elina Teicher, Hélène Fontaine, Dominique Salmon-Ceron, Laurence Meyer, Jean-Claude Trinchet, Bernard Paule, Didier Samuel, Maïté Lewin, Jean-Charles Duclos-Vallée, Do the epidemiology, physiological mechanisms and characteristics of hepatocellular carcinoma in HIV-infected patients justify specific screening policies?, AIDS, 2014, 28, 10, 1379

    CrossRef

  9. 9
    Maiyu Xu, Yi Wang, Lei Chen, Bujian Pan, Feng Chen, Yang Fang, Zhengping Yu, Gang Chen, Down-regulation of ribosomal protein S15A mRNA with a short hairpin RNA inhibits human hepatic cancer cell growth in vitro, Gene, 2014, 536, 1, 84

    CrossRef

  10. 10
    Jennifer C. Elliott, Efrat Aharonovich, Ann O’Leary, Milton Wainberg, Deborah S. Hasin, Drinking Motives Among HIV Primary Care Patients, AIDS and Behavior, 2014, 18, 7, 1315

    CrossRef

  11. 11
    Philippa C. Matthews, Anna Maria Geretti, Philip J.R. Goulder, Paul Klenerman, Epidemiology and impact of HIV coinfection with Hepatitis B and Hepatitis C viruses in Sub-Saharan Africa, Journal of Clinical Virology, 2014, 61, 1, 20

    CrossRef

  12. 12
    Jenny Stenkvist, Ola Weiland, Anders Sönnerborg, Anders Blaxhult, Karolin Falconer, High HCV treatment uptake in the Swedish HIV/HCV co-infected cohort, Scandinavian Journal of Infectious Diseases, 2014, 46, 9, 624

    CrossRef

  13. 13
    Reinhard H. Dennin, Michael Lafrenz, Georg Gesk, HIV and Other Sexual Transmitted Infections—Challenges for Liberal Prevention Strategies, World Journal of AIDS, 2014, 04, 02, 258

    CrossRef

  14. 14
    V. Martel-Laferriere, M. Wong, D. T. Dieterich, HIV/Hepatitis C Virus-Coinfected Patients and Cirrhosis: How to Diagnose It and What to Do Next?, Clinical Infectious Diseases, 2014, 58, 6, 840

    CrossRef

  15. 15
    Nicolás Merchante, Esperanza Merino, Francisco Rodríguez-Arrondo, Cristina Tural, Josefa Muñoz, Marcial Delgado-Fernández, Francisco Jover, Maria J. Galindo, Antonio Rivero, José López-Aldeguer, Koldo Aguirrebengoa, Alberto Romero-Palacios, Eduardo Martínez, Juan A. Pineda, HIV/hepatitis C virus-coinfected patients who achieved sustained virological response are still at risk of developing hepatocellular carcinoma, AIDS, 2014, 28, 1, 41

    CrossRef

  16. 16
    María Luisa Montes Ramírez, José M. Miró, Carmen Quereda, Antoni Jou, Miguel Ángel von Wichmann, Juan Berenguer, Juan J. González-García, Asunción Hernando, Enrique Ortega, José Sanz, José R. Arribas, Incidence of Hepatocellular Carcinoma in HIV-Infected Patients With Cirrhosis, JAIDS Journal of Acquired Immune Deficiency Syndromes, 2014, 65, 1, 82

    CrossRef

  17. 17
    Mayumi Tokunaga, Hirofumi Uto, Kohei Oda, Masahito Tokunaga, Seiichi Mawatari, Kotaro Kumagai, Kouichi Haraguchi, Makoto Oketani, Akio Ido, Nobuhito Ohnou, Atae Utsunomiya, Hirohito Tsubouchi, Influence of human T-lymphotropic virus type 1 coinfection on the development of hepatocellular carcinoma in patients with hepatitis C virus infection, Journal of Gastroenterology, 2014, 49, 12, 1567

    CrossRef

  18. 18
    Rachel H. Westbrook, Geoffrey Dusheiko, Natural history of hepatitis C, Journal of Hepatology, 2014, 61, 1, S58

    CrossRef

  19. 19
    George N. Ioannou, Lauren A. Beste, Pamela K. Green, Similar Effectiveness of Boceprevir and Telaprevir Treatment Regimens for Hepatitis C Virus Infection on the Basis of a Nationwide Study of Veterans, Clinical Gastroenterology and Hepatology, 2014, 12, 8, 1371

    CrossRef

  20. 20
    Wong Kuen Alencar, Paulo Schiavom Duarte, Eliseu Alves Waldman, Survival analysis of acquired immune deficiency syndrome patients with and without hepatitis C virus infection at a reference center for sexually transmitted diseases/acquired immune deficiency syndrome in São Paulo, Brazil, The Brazilian Journal of Infectious Diseases, 2014, 18, 2, 150

    CrossRef

  21. 21
    M. P. Curry, HIV and Hepatitis C Virus: Special Concerns for Patients With Cirrhosis, Journal of Infectious Diseases, 2013, 207, suppl 1, S40

    CrossRef

  22. 22
    Massimo Puoti, Maria Cristina Moioli, Roberto Rossotti, Giovanna Travi, Raffaele Bruno, Human immunodeficiency virus and hepatitis c virus coinfection: The agenda is full while waiting for new drugs, Hepatology, 2013, 57, 1
  23. 23
    A. Mancuso, C. Zavaglia, F. Bai, M. Puoti, L. S. Belli, Letter: sorafenib hepatotoxicity may be enhanced during treatment of advanced hepatocellular carcinoma in HIV-infected patients, Alimentary Pharmacology & Therapeutics, 2013, 38, 11-12
  24. 24
    Emily Dannhorn, James P O’Beirne, Liver transplantation for HIV/HCV coinfection: where is the controversy?, Future Virology, 2013, 8, 7, 639

    CrossRef

  25. 25
    Massimo Puoti, Roberto Rossotti, Giovanna Travi, Claudia Panzeri, Marco Morreale, Erika Chiari, Giorgia Cocca, Maurizio Orso, Maria Cristina Moioli, Optimizing treatment in HIV/HCV coinfection, Digestive and Liver Disease, 2013, 45, S355

    CrossRef

  26. 26
    G. N. Ioannou, J. D. Scott, Y. Yang, P. K. Green, L. A. Beste, Rates and predictors of response to anti-viral treatment for hepatitis C virus in HIV/HCV co-infection in a nationwide study of 619 patients, Alimentary Pharmacology & Therapeutics, 2013, 38, 11-12